Dysregulated ILC metabolism contributes to immune evasion in tumors and to pathogenic activation in autoimmune diseases such as inflammatory bowel disease (IBD) and systemic lupus erythematosus (SLE). The gene discussed is CCL27; the disease is systemic lupus erythematosus.